Problems viewing this newsletter? View it in your browser >

New On

July 1, 2016
Dear Advocate,
AVAC’s website and our P-Values blog have lots to explore and are constantly updated. If you haven’t visited recently, here’s a small sample of what you’ve missed:
"We Neglect Primary HIV Prevention at Our Peril"
The July issue of The Lancet HIV, launched online earlier this week, focuses on the need to scale up prevention to reduce new infections—reiterating that achieving UNAIDS’ 90-90-90 treatment targets is not possible otherwise.
Introducing Innovation: The role of devices in VMMC
Also this month, the Journal of AIDS (JAIDS) published a special supplement on devices for VMMC. The collection of articles examine safety, acceptability and operations research on implementation of two devices used to assist male circumcision in adults and adolescents—PrePex and ShangRing.
Announcing the Call for 2017 Fellows
AVAC’s Fellows program provides support to emerging and mid-career advocates to design and implement advocacy projects focused in their countries and communities. Consider applying and help us spread the word!
International AIDS Conference
AIDS 2016 will take place in Durban this month. We have details on how to follow along, from South Africa and online from afar, as well as a sortable conference roadmap available on our webpage.
CUREiculum Webinar Series
Our CUREiculum webinar series finished earlier this week with a great webinar, The Ethics of HIV Cure Research. To download the audio and slides from this or any of the previous webinars in the series, click here.
Ongoing and Planned PrEP Demonstration and Implementation Studies
Our summary table of global PrEP evaluation studies was recently updated. A PDF and sortable Excel version are available for download.
HIV Vaccine Awareness Day Materials
AVAC worked with partners to develop a range of tools and resources with the latest on HIV vaccine research. These were developed for HVAD but useful year-round, click here for the full toolkit.

Understanding the Potential for Multipurpose Prevention of Pregnancy and HIV
A paper on the results from a quantitative market research survey of nearly 2,000 women in Uganda, Nigeria and South Africa, which seeks to understand women’s preferences and willingness to try various hypothetical multipurpose prevention concepts to achieve dual protection from pregnancy and HIV.
USAID Reaffirms Commitment to HIV Vaccine and Biomedical Prevention Research and Advocacy
The US Agency for International Development just awarded two new grants to advance HIV vaccine and biomedical prevention research: one to the International AIDS Vaccine Initiative (IAVI) and the second to AVAC.

Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 

Contact Us T: +1 212 796 6423